Inhibitory and stimulatory effects of IL-10 on human CD8+ T cells
- PMID: 9531274
Inhibitory and stimulatory effects of IL-10 on human CD8+ T cells
Abstract
IL-10 is a well-documented immunosuppressant that inhibits macrophage-dependent Ag presentation and CD4+ T cell proliferation in vitro. We report that IL-10 inhibits alloantigen-specific proliferative responses and induces a long lasting anergic state in human purified CD8+ T cells when added concomitantly with the Ag in the presence of APC. Moreover, the generation of allospecific cytotoxic activity is inhibited by IL-10. These effects are indirect and are mediated through inhibition of the costimulatory functions of APC. In contrast, IL-10 has no direct inhibitory effects on the proliferation of purified CD8+ T cells activated by anti-CD3 mAb and promotes the growth of activated CD8+ T cells in combination with low doses of IL-2. Taken together, these results indicate that IL-10 has differential effects on CD8+ T cells depending on their state of activation, which may explain both the enhancing and inhibitory effects observed after IL-10 treatment in different in vivo experimental models.
Similar articles
-
T helper-independent activation of human CD8+ cells: the role of CD28 costimulation.Scand J Immunol. 1996 Jul;44(1):21-9. doi: 10.1046/j.1365-3083.1996.d01-82.x. Scand J Immunol. 1996. PMID: 8693288
-
Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.J Immunol. 1993 Jun 1;150(11):4754-65. J Immunol. 1993. PMID: 7684412
-
B cells activated by lipopolysaccharide, but not by anti-Ig and anti-CD40 antibody, induce anergy in CD8+ T cells: role of TGF-beta 1.J Immunol. 2003 Jun 15;170(12):5897-911. doi: 10.4049/jimmunol.170.12.5897. J Immunol. 2003. PMID: 12794116
-
Induction of tolerance by IL-10-treated dendritic cells.J Immunol. 1997 Nov 15;159(10):4772-80. J Immunol. 1997. PMID: 9366401
-
CD80, CD86 and CD40 provide accessory signals in a multiple-step T-cell activation model.Immunol Rev. 1996 Oct;153:47-83. doi: 10.1111/j.1600-065x.1996.tb00920.x. Immunol Rev. 1996. PMID: 9010719 Review.
Cited by
-
Mechanisms of Altered Immune Response in Skin Melanoma.Curr Health Sci J. 2023 Jul-Sep;49(3):297-311. doi: 10.12865/CHSJ.49.03.01. Epub 2023 Sep 30. Curr Health Sci J. 2023. PMID: 38314217 Free PMC article. Review.
-
Glioblastoma vaccines: past, present, and opportunities.EBioMedicine. 2024 Feb;100:104963. doi: 10.1016/j.ebiom.2023.104963. Epub 2024 Jan 5. EBioMedicine. 2024. PMID: 38183840 Free PMC article. Review.
-
Petiveria alliacea Reduces Tumor Burden and Metastasis and Regulates the Peripheral Immune Response in a Murine Myeloid Leukemia Model.Int J Mol Sci. 2023 Aug 19;24(16):12972. doi: 10.3390/ijms241612972. Int J Mol Sci. 2023. PMID: 37629156 Free PMC article.
-
Liquid nitrogen frozen cells for chemotherapy drug delivery and vaccination of melanoma.J Cancer Res Clin Oncol. 2023 Nov;149(15):13705-13716. doi: 10.1007/s00432-023-05117-y. Epub 2023 Jul 31. J Cancer Res Clin Oncol. 2023. PMID: 37522925
-
Development of Adaptive Immunity and Its Role in Lung Remodeling.Adv Exp Med Biol. 2023;1426:287-351. doi: 10.1007/978-3-031-32259-4_14. Adv Exp Med Biol. 2023. PMID: 37464127
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Research Materials